Single peptide Vial strength 15 mg
Semaglutide15 mg
Explore the format, calculations, and schedules reported for this compound.
Back to peptides
Get to know the compound
Semaglutide, explained simply
A GLP-1 receptor agonist with extensive clinical research that should be read in the context of the studied product and population.
Research area
Weight and metabolism
How it works
Semaglutide is a GLP-1 receptor agonist that affects appetite, satiety, and blood glucose regulation.
Why it matters
This profile separates data from studied medicines and clinical trials from calculations for generic vials.
What has been observed
Clinical programs examine weight management and other metabolic outcomes in defined populations.
Effects and points to consider
The indication, formulation, and product documentation determine whether clinical findings apply.
01 / Vial strength 15 mg
Reported data
Doses and cycles are presented for information and education only; they are not prescriptions or medical advice.
Reported vial strength and reconstitution
| Vial contents | 15 mg Semaglutide |
|---|---|
| Final volume | 3 mL |
| Concentration | 5 mg/mL |
| One U-100 unit | 50 mcg in 0.01 mL |
Standard Weekly Escalation Schedule (3 mL = 5 mg/mL)
| Study Phase | Weekly Amount | U-100 Units | Volume |
|---|---|---|---|
| Weeks 1 to 4 | 0.25 mg | 5 units | 0.05 mL |
| Weeks 5 to 8 | 0.5 mg | 10 units | 0.1 mL |
| Weeks 9 to 12 | 1 mg | 20 units | 0.2 mL |
| Weeks 13 to 16 | 1.7 mg | 34 units | 0.34 mL |
| Weeks 17+ | 2.4 mg | 48 units | 0.48 mL |
Supplies needed
View on Amazon
Sterile alcohol swabs
SOURCES
Scientific references
Links reported by the source and selected by type. Their presence does not validate this page’s dosage data.